Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Anaesthesia Effectiveness in Symptomatic Irreversible Pulpitis
NCT06862570Phase 2Completed
- Sponsor
- 28 Military Dental Centre Lahore
- Start
- Dec 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in irreversible pulpitis comparing 2% LIGNOCAINE WITH EPINEPHRINE with 4% ARTICAINE WITH EPINEPHRINE (2 arms). Primary endpoint: Assessment of Local Anaesthesia Effectiveness. Started Dec 2022; status: completed.
02
Drugs
lidocainearticaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06862570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06862570.